Clinical Trials Logo

Clinical Trial Summary

Patients who receive smartphone-assisted health coaching will have a significantly lower 24 hour ambulatory blood pressure mean than patients who receive just health coaching


Clinical Trial Description

Primary Outcome Measure: Mean 24 hour ambulatory blood pressure

Secondary Outcome Measures: Profile of Mood States-SF Vigor Scale; Satisfaction with Life Scale; Positive and Negative Affect Schedule; Hospital Anxiety and Depression Scale; SF - 12 ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02032719
Study type Interventional
Source York University
Contact Paul Ritvo, PhD
Phone 4165808021
Email pritvo@yorku.ca
Status Recruiting
Phase Phase 3
Start date January 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Completed NCT00151229 - Valsartan in Elderly Isolated Systolic Hypertension Study Phase 4
Recruiting NCT04755764 - Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Completed NCT03712033 - TEC4Home Stroke - Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients
Completed NCT00940966 - A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome N/A
Recruiting NCT06084065 - Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device N/A
Completed NCT01755572 - Blood Pressure Outcomes With Liraglutide Therapy Phase 4
Completed NCT01281306 - An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension Phase 2